Annual CFO
-$331.73 M
-$34.04 M-11.43%
31 December 2023
Summary:
Biohaven Pharmaceutical Holding annual cash flow from operations is currently -$331.73 million, with the most recent change of -$34.04 million (-11.43%) on 31 December 2023. During the last 3 years, it has fallen by -$255.77 million (-336.73%). BHVN annual CFO is now -5797.33% below its all-time high of -$5.63 million, reached on 31 December 2015.BHVN Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$141.28 M
+$26.52 M+15.81%
30 September 2024
Summary:
Biohaven Pharmaceutical Holding quarterly cash flow from operations is currently -$141.28 million, with the most recent change of +$26.52 million (+15.81%) on 30 September 2024. Over the past year, it has dropped by -$46.46 million (-49.00%). BHVN quarterly CFO is now -9044.08% below its all-time high of -$1.54 million, reached on 01 March 2016.BHVN Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$526.59 M
-$46.46 M-9.68%
30 September 2024
Summary:
Biohaven Pharmaceutical Holding TTM cash flow from operations is currently -$526.59 million, with the most recent change of -$46.46 million (-9.68%) on 30 September 2024. Over the past year, it has dropped by -$234.34 million (-80.18%). BHVN TTM CFO is now -33983.62% below its all-time high of -$1.54 million, reached on 01 March 2016.BHVN TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BHVN Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -11.4% | -49.0% | -80.2% |
| 3 y3 years | -336.7% | - | - |
| 5 y5 years | -68.3% | -40.6% | -39.6% |
BHVN Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -336.7% | at low | -218.2% | +15.8% | -795.0% | at low |
| 5 y | 5 years | -336.7% | +12.1% | -218.2% | +33.4% | -795.0% | +25.1% |
| alltime | all time | -5797.3% | +12.1% | -9044.1% | +33.4% | <-9999.0% | +25.1% |
Biohaven Pharmaceutical Holding Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$141.28 M(-15.8%) | -$526.59 M(+9.7%) |
| June 2024 | - | -$167.80 M(+63.5%) | -$480.13 M(+34.6%) |
| Mar 2024 | - | -$102.64 M(-10.7%) | -$356.72 M(+7.5%) |
| Dec 2023 | -$331.73 M(+11.4%) | -$114.88 M(+21.2%) | -$331.73 M(+13.5%) |
| Sept 2023 | - | -$94.81 M(+113.6%) | -$292.25 M(-0.3%) |
| June 2023 | - | -$44.39 M(-42.8%) | -$293.00 M(-7.4%) |
| Mar 2023 | - | -$77.64 M(+3.0%) | -$316.49 M(+6.3%) |
| Dec 2022 | -$297.69 M(+104.1%) | -$75.41 M(-21.1%) | -$297.69 M(+33.9%) |
| Sept 2022 | - | -$95.56 M(+40.8%) | -$222.28 M(+75.4%) |
| June 2022 | - | -$67.89 M(+15.4%) | -$126.72 M(+115.4%) |
| Mar 2022 | - | -$58.84 M(-72.3%) | -$58.84 M(-91.6%) |
| Dec 2021 | -$145.84 M(+92.0%) | - | - |
| Dec 2020 | -$75.96 M(-79.9%) | - | - |
| Dec 2020 | - | -$212.24 M(+29.3%) | -$702.88 M(+18.9%) |
| Sept 2020 | - | -$164.11 M(-6.7%) | -$591.09 M(+18.9%) |
| June 2020 | - | -$175.81 M(+16.6%) | -$497.11 M(+3.3%) |
| Mar 2020 | - | -$150.72 M(+50.1%) | -$481.18 M(+27.5%) |
| Dec 2019 | -$377.33 M | - | - |
| Dec 2019 | - | -$100.45 M(+43.2%) | -$377.33 M(+21.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2019 | - | -$70.13 M(-56.1%) | -$310.30 M(+7.4%) |
| June 2019 | - | -$159.89 M(+241.1%) | -$288.91 M(+77.8%) |
| Mar 2019 | - | -$46.87 M(+40.3%) | -$162.48 M(-17.6%) |
| Dec 2018 | -$197.14 M(+107.9%) | - | - |
| Dec 2018 | - | -$33.42 M(-31.4%) | -$197.14 M(-3.6%) |
| Sept 2018 | - | -$48.74 M(+45.7%) | -$204.49 M(+15.5%) |
| June 2018 | - | -$33.46 M(-59.0%) | -$177.10 M(+5.0%) |
| Mar 2018 | - | -$81.53 M(+100.0%) | -$168.70 M(+77.9%) |
| Dec 2017 | -$94.81 M(+221.4%) | - | - |
| Dec 2017 | - | -$40.77 M(+91.0%) | -$94.81 M(+35.3%) |
| Sept 2017 | - | -$21.35 M(-14.8%) | -$70.10 M(+22.1%) |
| June 2017 | - | -$25.05 M(+227.4%) | -$57.42 M(+61.3%) |
| Mar 2017 | - | -$7.65 M(-52.3%) | -$35.61 M(+20.7%) |
| Dec 2016 | -$29.50 M(+424.5%) | - | - |
| Dec 2016 | - | -$16.05 M(+85.2%) | -$29.50 M(+119.4%) |
| Sept 2016 | - | -$8.67 M(+167.9%) | -$13.45 M(+181.3%) |
| June 2016 | - | -$3.24 M(+109.4%) | -$4.78 M(+209.4%) |
| Mar 2016 | - | -$1.54 M | -$1.54 M |
| Dec 2015 | -$5.63 M | - | - |
FAQ
- What is Biohaven Pharmaceutical Holding annual cash flow from operations?
- What is the all time high annual CFO for Biohaven Pharmaceutical Holding?
- What is Biohaven Pharmaceutical Holding annual CFO year-on-year change?
- What is Biohaven Pharmaceutical Holding quarterly cash flow from operations?
- What is the all time high quarterly CFO for Biohaven Pharmaceutical Holding?
- What is Biohaven Pharmaceutical Holding quarterly CFO year-on-year change?
- What is Biohaven Pharmaceutical Holding TTM cash flow from operations?
- What is the all time high TTM CFO for Biohaven Pharmaceutical Holding?
- What is Biohaven Pharmaceutical Holding TTM CFO year-on-year change?
What is Biohaven Pharmaceutical Holding annual cash flow from operations?
The current annual CFO of BHVN is -$331.73 M
What is the all time high annual CFO for Biohaven Pharmaceutical Holding?
Biohaven Pharmaceutical Holding all-time high annual cash flow from operations is -$5.63 M
What is Biohaven Pharmaceutical Holding annual CFO year-on-year change?
Over the past year, BHVN annual cash flow from operations has changed by -$34.04 M (-11.43%)
What is Biohaven Pharmaceutical Holding quarterly cash flow from operations?
The current quarterly CFO of BHVN is -$141.28 M
What is the all time high quarterly CFO for Biohaven Pharmaceutical Holding?
Biohaven Pharmaceutical Holding all-time high quarterly cash flow from operations is -$1.54 M
What is Biohaven Pharmaceutical Holding quarterly CFO year-on-year change?
Over the past year, BHVN quarterly cash flow from operations has changed by -$46.46 M (-49.00%)
What is Biohaven Pharmaceutical Holding TTM cash flow from operations?
The current TTM CFO of BHVN is -$526.59 M
What is the all time high TTM CFO for Biohaven Pharmaceutical Holding?
Biohaven Pharmaceutical Holding all-time high TTM cash flow from operations is -$1.54 M
What is Biohaven Pharmaceutical Holding TTM CFO year-on-year change?
Over the past year, BHVN TTM cash flow from operations has changed by -$234.34 M (-80.18%)